SEC Filings

10-Q
MEDTRONIC PLC filed this Form 10-Q on 09/01/2017
Entire Document
 
Medtronic plc
Notes to Consolidated Financial Statements
(Unaudited)


Condensed Consolidating Statement of Cash Flows
Three Months Ended July 29, 2016
CIFSA Senior Notes
(in millions)
Medtronic plc
 
CIFSA
 
CIFSA Subsidiary Guarantors
 
Subsidiary Non-guarantors
 
Consolidating
Adjustments
 
Total
Operating Activities:
 
 
 
 
 
 
 
 
 
 
 
Net cash provided by (used in) operating activities
$
440

 
$
(7
)
 
$

 
$
1,117

 
$

 
$
1,550

Investing Activities:
 
 
 
 
 
 
 
 
 
 
 
Acquisitions, net of cash acquired

 

 

 
(12
)
 

 
(12
)
Additions to property, plant, and equipment

 

 

 
(330
)
 

 
(330
)
Purchases of investments

 

 

 
(1,044
)
 

 
(1,044
)
Sales and maturities of investments

 

 

 
1,104

 

 
1,104

Net (increase) decrease in intercompany loans

 
4,290

 
(1,774
)
 
3,334

 
(5,850
)
 

Capital contributions paid

 
(325
)
 

 

 
325

 

Other investing activities, net

 

 

 
(2
)
 

 
(2
)
Net cash provided by (used in) investing activities

 
3,965

 
(1,774
)
 
3,050

 
(5,525
)
 
(284
)
Financing Activities:
 
 
 
 
 
 
 
 
 
 
 
Acquisition-related contingent consideration

 

 

 
(11
)
 

 
(11
)
Change in current debt obligations, net

 

 
975

 
(49
)
 

 
926

Issuance of long-term debt

 

 

 
33

 

 
33

Payments on long-term debt

 

 

 
(17
)
 

 
(17
)
Dividends to shareholders
(599
)
 

 

 

 

 
(599
)
Issuance of ordinary shares
214

 

 

 

 

 
214

Repurchase of ordinary shares
(1,763
)
 

 

 

 

 
(1,763
)
Net intercompany loan borrowings (repayments)
1,708

 
(4,081
)
 
854

 
(4,331
)
 
5,850

 

Capital contributions received

 

 

 
325

 
(325
)
 

Other financing activities

 

 

 
57

 

 
57

Net cash provided by (used in) financing activities
(440
)
 
(4,081
)
 
1,829

 
(3,993
)
 
5,525

 
(1,160
)
Effect of exchange rate changes on cash and cash equivalents

 

 

 
78

 

 
78

Net change in cash and cash equivalents

 
(123
)
 
55

 
252

 

 
184

Cash and cash equivalents at beginning of period

 
208

 

 
2,668

 

 
2,876

Cash and cash equivalents at end of period
$

 
$
85

 
$
55

 
$
2,920

 
$

 
$
3,060



45

X